Want to join the conversation?
$XRAY 2Q15 PR: Bret Wise, DENTSPLY's Chairman and CEO, stated "Given our first half results, recent strength in the US market, and in light of a relatively stable European dental market, we are increasing our full-year adjusted earnings guidance to the range of $2.54 to $2.62 per diluted share from $2.50 to $2.60 per share, previously."
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.